References
- Rumack B J, Lovejoy F, Jr. Clinical toxicology. Casarett and Donll's Toxicology, the basic science of poisons. 4th ed., M O Amdur, J Doull, C D Klaassen. Pergamon Press, New York 1991; 924–46
- Joiner R L, Dill G S, Hobson D W, Snider T H. 1989, Final report for Task 85–12, Comparison of the effectiveness of 30 experimental decontamination systems and evaluation of the effect of three pretreatment materials against percutaneous application of Soman (GD), thickened Soman (TGD), VX, and sulfur mustard (HD) to the rabbit; Contract No. DAMD17–83-C-3129
- Joiner R L, Keys W B, Harroff H H, Jr, Snider T H. 1988, Final report for Task 86–25, Evaluation of the effectiveness of two Rohm & Haas candidate decontamination systems against percutaneous application of undiluted TGD, GD, VX, HD, and L on the laboratory albino rabbit; Contract No. DAMD17–83-C-3129
- Taylor P. Anticholinesterase agents. Goodman and Oilman's The pharmacological basis of therapeutics. 8th ed., A G Gilman, T W Rall, A S Nies, P Taylor. Pergamon Press, New York 1985; 131–49
- Murphy S D. Pesticides. Casarett and Doull's Toxicology, The basic science of poisons. 2nd ed., J Doull, C D Klaassen, M O Amdur. Macmillan, New York 1980; 357–408
- Olson C T, Feder P I, Hobson D W, Kiser R C, Joiner R L. Evaluation of compounds as barriers to dermal penetration of organophosphates using acetylcholinesterase inhibition. Toxicol Lett 1991; 55: 325–34
- Finney D J. The comparison of effectiveness, Probit analysis. 3rd ed. Cambridge University Press, New York 1971; 119–21
- Feder P I, Hobson D W, Olson C T, Joiner R L, Matthews M C. Stagewise, group sequential experimental designs for comparisons of quantal response levels obtained with candidate treatment regimens versus those with a concurrent control or a specified standard. Biopharmaceutical sequential statistical applications, K E Peace. Marcel Dekker, New York 1992; 87–116
- Ellman G L, Courtney K D, Andres V, Jr, Featherstone R M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88–95
- Geller N L, Pocock S J. Design and analysis of clinical trials with group sequential stopping rules. Biopharmaceutical statistics for drug development, K E Peace. Marcel Dekker, New York 1988; 489–508